Tunable TriPcides suppress virulence factor secretion during Staphylococcus aureus infection and kill dormant cells

Hasan Tükenmez1,2, Taylor M Nye3, Pardeep Singh4

  • 1Nordic BioConsult AB, SE-91332, Holmsund, Sweden.

Science Advances
|May 6, 2026
PubMed

Insights

New TriPcides combat antibiotic-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA). These compounds kill resistant MRSA and persister cells without inducing resistance, offering a promising new treatment avenue.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antimicrobial resistance (AMR) is a major global health crisis.
  • Methicillin-resistant Staphylococcus aureus (MRSA) causes a significant portion of S. aureus infections.
  • Existing treatments are becoming less effective against resistant bacterial strains.

Purpose of the Study:

  • To develop novel therapeutic agents against MRSA.
  • To identify compounds effective against antibiotic-resistant and persister MRSA cells.
  • To evaluate the mechanism of action and in vivo efficacy of new compounds.

Main Methods:

  • Synthesis and characterization of a novel class of tunable three-dimensional tricyclic 2-pyridones (TriPcides).
  • Testing TriPcides against clinical isolates of MRSA, including those resistant to last-resort antibiotics.
  • Assessing MRSA resistance development through continuous exposure experiments.
  • Investigating the mode of action, including effects on membrane integrity and reactive oxygen species (ROS) levels.
  • Evaluating TriPcides in a murine model of S. aureus skin and soft tissue infection.

Main Results:

  • TriPcides demonstrated potent activity against MRSA, including strains resistant to conventional antibiotics.
  • No pre-existing or induced resistance to TriPcides was observed in MRSA isolates.
  • Treatment with TriPcides led to rapid loss of membrane integrity and increased ROS production.
  • TriPcides reduced virulence factor secretion and improved healing in a murine infection model, without reducing bacterial load.

Conclusions:

  • TriPcides represent a novel class of compounds effective against challenging MRSA infections.
  • These compounds offer a new strategy to combat AMR by targeting resistant and persister MRSA cells.
  • Further investigation into TriPcides is warranted for their potential clinical application in treating S. aureus infections.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...